These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 28389129)

  • 1. Sirtuin Inhibition: Strategies, Inhibitors, and Therapeutic Potential.
    Jiang Y; Liu J; Chen D; Yan L; Zheng W
    Trends Pharmacol Sci; 2017 May; 38(5):459-472. PubMed ID: 28389129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The chemical biology of sirtuins.
    Chen B; Zang W; Wang J; Huang Y; He Y; Yan L; Liu J; Zheng W
    Chem Soc Rev; 2015 Aug; 44(15):5246-64. PubMed ID: 25955411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemical Probes in Sirtuin Research.
    Hu X; Zheng W
    Prog Mol Biol Transl Sci; 2018; 154():1-24. PubMed ID: 29413174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sirtuins inhibitors: the approach to affinity and selectivity.
    Cen Y
    Biochim Biophys Acta; 2010 Aug; 1804(8):1635-44. PubMed ID: 19931429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An overview of Sirtuins as potential therapeutic target: Structure, function and modulators.
    Wang Y; He J; Liao M; Hu M; Li W; Ouyang H; Wang X; Ye T; Zhang Y; Ouyang L
    Eur J Med Chem; 2019 Jan; 161():48-77. PubMed ID: 30342425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Review: The plant sirtuins.
    Zheng W
    Plant Sci; 2020 Apr; 293():110434. PubMed ID: 32081272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinetic and Structural Basis for Acyl-Group Selectivity and NAD(+) Dependence in Sirtuin-Catalyzed Deacylation.
    Feldman JL; Dittenhafer-Reed KE; Kudo N; Thelen JN; Ito A; Yoshida M; Denu JM
    Biochemistry; 2015 May; 54(19):3037-3050. PubMed ID: 25897714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The mimics of N
    Wang C; Wang F; Chen X; Zou Y; Zhu H; Zhao Q; Shen J; Li Y; Li Y; He B
    Bioorg Med Chem Lett; 2018 Aug; 28(14):2375-2378. PubMed ID: 29921476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sirtuin mechanism and inhibition: explored with N(ε)-acetyl-lysine analogs.
    Hirsch BM; Zheng W
    Mol Biosyst; 2011 Jan; 7(1):16-28. PubMed ID: 20842312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-activity studies on suramin analogues as inhibitors of NAD+-dependent histone deacetylases (sirtuins).
    Trapp J; Meier R; Hongwiset D; Kassack MU; Sippl W; Jung M
    ChemMedChem; 2007 Oct; 2(10):1419-31. PubMed ID: 17628866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simple N(ε)-thioacetyl-lysine-containing cyclic peptides exhibiting highly potent sirtuin inhibition.
    Huang Y; Liu J; Yan L; Zheng W
    Bioorg Med Chem Lett; 2016 Mar; 26(6):1612-1617. PubMed ID: 26874402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural basis of inhibition of the human NAD+-dependent deacetylase SIRT5 by suramin.
    Schuetz A; Min J; Antoshenko T; Wang CL; Allali-Hassani A; Dong A; Loppnau P; Vedadi M; Bochkarev A; Sternglanz R; Plotnikov AN
    Structure; 2007 Mar; 15(3):377-89. PubMed ID: 17355872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Selective Cyclic Peptidic Human SIRT5 Inhibitor.
    Liu J; Huang Y; Zheng W
    Molecules; 2016 Sep; 21(9):. PubMed ID: 27626398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxadiazole-carbonylaminothioureas as SIRT1 and SIRT2 inhibitors.
    Huhtiniemi T; Suuronen T; Rinne VM; Wittekindt C; Lahtela-Kakkonen M; Jarho E; Wallén EA; Salminen A; Poso A; Leppänen J
    J Med Chem; 2008 Aug; 51(15):4377-80. PubMed ID: 18642893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism-based modulator discovery for sirtuin-catalyzed deacetylation reaction.
    Zheng W
    Mini Rev Med Chem; 2013 Jan; 13(1):132-54. PubMed ID: 22876953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-based development of novel sirtuin inhibitors.
    Schlicker C; Boanca G; Lakshminarasimhan M; Steegborn C
    Aging (Albany NY); 2011 Sep; 3(9):852-72. PubMed ID: 21937767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sirt5 deacylation activities show differential sensitivities to nicotinamide inhibition.
    Fischer F; Gertz M; Suenkel B; Lakshminarasimhan M; Schutkowski M; Steegborn C
    PLoS One; 2012; 7(9):e45098. PubMed ID: 23028781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Function and regulation of the mitochondrial sirtuin isoform Sirt5 in Mammalia.
    Gertz M; Steegborn C
    Biochim Biophys Acta; 2010 Aug; 1804(8):1658-65. PubMed ID: 19766741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sirtuins: multifaceted drug targets.
    Chakrabarty SP; Balaram H; Chandrasekaran S
    Curr Mol Med; 2011 Dec; 11(9):709-18. PubMed ID: 21999152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic potential of activators and inhibitors of sirtuins.
    Balcerczyk A; Pirola L
    Biofactors; 2010; 36(5):383-93. PubMed ID: 20848588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.